In combination with clinicopathologic features, MCM4 expression was associated with high grade (P < 0.0001) and non-papillary morphology (P = 0.0059), while no statistical difference between MCM4 and stage in the TCGA BC data was found (Supplementary Fig. 2B-D). This evidence concerns the gene MCM4 and breast cancer.